• 제목/요약/키워드: University of Oxford

Search Result 210, Processing Time 0.064 seconds

The Belt and Road Initiative (BRI): Opportunities and Risks from Vietnamese Perspective

  • NGUYEN, Long Duc Bao;LY, Tracy Trang;TRAN, Doan Cong;TRAN, Ai Van;LE, An Quoc;HUDSON, Alan
    • The Journal of Asian Finance, Economics and Business
    • /
    • v.9 no.4
    • /
    • pp.229-238
    • /
    • 2022
  • The goal of this research is to look at the Belt and Road Initiative's (BRI) goals, principles, and priorities, as well as criticisms and concerns. Another goal is to determine the Vietnamese government's best response to the BRI. Finally, the study looks at the Vietnamese viewpoint. Document review is used in conjunction with PESTELED analysis and EIU country risk model technique in this study. The study is focused on in-depth interviews with 38 top government leaders, researchers, and scholars by adopting the Delphi technique to determine major factors of risks and opportunities as well as obtain a clearer view on the Vietnamese perspective of the BRI. The main conclusion is that Vietnam's participation in the BRI could result in a variety of benefits and risks, including economic development, connectivity and integration, development finance, cooperation, coordination, trade facilitation, and people-to-people communication, as well as diplomatic and political risks, financial risks, environmental challenges, and job creation. Another conclusion is suggested that careful and case-by-case negotiation with China is needed for Vietnam to exploit the future benefits of BRI. There is a need to set up the strategy to mitigate the risk impacts, reduce the risk level, avoid risk, at last turn the risk into opportunities.

Regional Innovation Systems of Oxford, UK: Their Origin and Key Actors (대학 중심 지역혁신의 기원과 주체: 영국 옥스퍼드지역을 사례로)

  • Shin, Dong-Ho
    • Journal of the Economic Geographical Society of Korea
    • /
    • v.25 no.2
    • /
    • pp.219-236
    • /
    • 2022
  • The Oxford area is one of the major innovative regions of the world. The innovative characteristics of the area, however, have not been well exposed to the academic communities of the world and Korea. In fact, the area was a base of breading the Cambridge area and has also been playing important roles in creating the major British high-technology region, called "Golden Triangle," composed of Oxford, Cambridge and London. This paper investigates the process of growing innovativeness of the Oxford area and sheds more lights on the birth, growth and key actors of the area's Regional Innovation Systems(RISs). For this research, the author reviewed the literature related to the RISs, and gathered data based on the Internet, statistical data sources, interviews with local scholars and practitioners.

DESIGN AND ANALYSIS OF RANDOMIZED CLINICAL TRIALS REQUIRING PROLONGED OBSERVATION OF EACH PATIENT I. INTRODUCTION AND DESIGN

  • Peto R.;Pike M.C.;Armitage P.;Breslow N.E.;Cox D.R.;Howard S.V.;Mantel N.;Mcpherson K.;Peto J.;Smith P.G.
    • 대한예방의학회:학술대회논문집
    • /
    • 1994.02b
    • /
    • pp.206-233
    • /
    • 1994
  • The Medical Research Council has for some years encouraged collaborative clinical trials in leukaemia and other cancers, reporting the results in the medical literature. One unreported result which deserves such publication is the development of the expertise to design and analyse such trials. This report was prepared by a group of British and American statisticians, but it is intended for people without any statistical expertise. Part!, which appears in this issue, discusses the design of such trials; Part II, which will appear separately in the January 1977 issue of the Journal, gives full instructions for the statistical analysis of such trials by means of life tables and the logrank test, including a worked example, and discusses the interpretation of trial results, including brief reports of particular trials. Both parts of this report are relevant to all clinical trials which study time to death, and would be equally relevant to clinical trials which study time to other particular classes of untoward event: first stroke, perhaps, or first relapse, metastasis, disease recurrence, thrombosis, transplant rejection, or death from a particular cause. Part I, in this issue, collects together ideas that have mostly already appeared in the medical literature, but Part II, next month, is the first simple account yet published for non-statistical physicians of how to analyse efficiently data from clinical trials of survival duration. Such trials include the majority of all clinical trials of cancer therapy; in cancer trials, however, it may be preferable to use these statistical methods to study time to local recurrence of tumour, or to study time to detectable metastatic spread, in addition to studying total survival. Solid tumours can be staged at diagnosis; if this, or any other available information in some other disease is an important determinant of outcome, it can be used to make the overall logrank test for the whole heterogeneous trial population more sensitive, and more intuitively satisfactory, for it will then only be necessary to compare like with like, and not, by chance, Stage I with Stage III.

  • PDF